How Did a Lower Outlook Push USANA Health Sciences (NYSE:USNA) Down 9.21% Pre-Market?

Vinay Lochav

04 November 2026 11:32 PM AEDT

How Did a Lower Outlook Push USANA Health Sciences (NYSE:USNA) Down 9.21% Pre-Market?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Shares dropped 9.21% to USD 13.50 in pre-market trading on November 4, 2026.
Third quarter net sales came in at USD 205.9 million, below USD 213.7 million a year earlier.
Core Nutritional active customers declined 8% to 356,000 from 388,000.
Fiscal 2026 adjusted diluted EPS guidance was lowered to USD 0.55 from USD 0.76.
Cash stood at USD 178.9 million with no Debt outstanding at quarter end.

What Weighed on USANA Before the Open (down USD 1.37, 9.21%)

USANA Health Sciences, Inc. (NYSE:USNA) slipped 9.21%, or USD 1.37, to USD 13.50 in pre-market trading on November 4, 2026, measured against the November 3, 2026 close. The trigger was the company's third quarter 2026 Earnings release, issued on November 3, 2026, which showed lower sales, a shrinking core customer base and a smaller full year outlook. Chief Executive Kevin Guest called the quarter mixed.

Quarterly Results and the Updated Outlook

For the fiscal quarter ended October 3, 2026, net sales were USD 205.9 million, down 3.6% from USD 213.7 million. The company moved to an operating loss of USD 1.4 million from Operating Income of USD 1.2 million. Net loss attributable to USANA was USD 5.6 million, or USD 0.30 per diluted share, against USD 6.5 million, or USD 0.36, a year earlier. Adjusted diluted EPS was a loss of USD 0.11 versus a loss of USD 0.15, and adjusted EBITDA was USD 12.1 million compared with USD 13.8 million, down 13%.

For fiscal 2026, the company now expects net sales approaching USD 900 million, down from USD 910 million previously. Net loss is guided to USD 16 million, or USD 0.90 per share, from USD 11 million, or USD 0.61. Adjusted diluted EPS guidance moved to USD 0.55 from USD 0.76, and adjusted EBITDA to USD 77 million from USD 80.5 million as corrected. The company also corrected second quarter adjusted EBITDA to USD 21.7 million from USD 27.8 million.

Company Overview and Segment Breakdown

USANA develops and sells science based nutritional supplements and personal care products through a direct selling network. It also runs the Hiya children's vitamin subscription Business and Rise Wellness.

Core Nutritional net sales were USD 170.7 million, down 3.1%, while active customers fell 8% to 356,000 from 388,000. Hiya net sales rose 2.3% to USD 31.5 million, with active monthly subscribers at 195,500 against 193,400. The company said Target and Amazon sales more than doubled from the second quarter. Rise Wellness sales fell 44.8% to USD 3.6 million.

Balance Sheet and Risks

Cash and equivalents totaled USD 178.9 million. The USD 14 million line of Credit that was outstanding at January 3, 2026 has been repaid, leaving no debt. Free Cash Flow was USD 8.4 million in the quarter and USD 35.7 million year to date. The company made no share repurchases in the quarter.

The main risks are the shrinking Core Nutritional customer count, a large Goodwill Impairment already recorded at Hiya, and the second quarter correction, which raises questions about reporting precision.

Next Steps to Track

The fourth quarter is the next test. Management expects sequential improvement in Hiya net sales and adjusted EBITDA, with further Hiya updates due in early 2027. Core customer trends, any restart of Buybacks and the level of cost savings will shape sentiment.

FAQs

Q: Why is USANA down in pre-market trading on November 4, 2026?

A: The shares were down 9.21% to USD 13.50 after third quarter net sales fell 3.6% to USD 205.9 million and the company cut its fiscal 2026 net sales and adjusted EPS guidance.

Q: What is USANA's updated fiscal 2026 outlook?

A: The company now expects net sales approaching USD 900 million, adjusted diluted EPS of USD 0.55 and adjusted EBITDA of USD 77 million, according to its November 3, 2026 release.

Q: Does USANA have debt?

A: According to the release, the company had USD 178.9 million of cash and no debt at the end of the third quarter after repaying its USD 14 million line of credit.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.